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Hyaluronate lyase enzymes degrade hyaluronan, the
main polysaccharide component of the host connective
tissues, predominantly into unsaturated disaccharide
units, thereby destroying the normal connective tissue
structure and exposing the tissue cells to various endo-
and exogenous factors, including bacterial toxins. The
crystal structures of Streptococcus pneumoniae hyaluro-
nate lyase with tetra- and hexasaccharide hyaluronan
substrates bound in the active site were determined at
1.52- and 2.0-Å resolution, respectively. Hexasaccharide
is the longest substrate segment that binds entirely
within the active site of these enzymes. The enzyme
residues responsible for substrate binding, positioning,
catalysis, and product release were thereby identified
and their specific roles characterized. The involvement
of three residues in catalysis, Asn349, His399, and Tyr408,
is confirmed, and the details of proton acceptance and
donation within the catalytic machinery are described.
The mechanism of processivity of the enzyme is ana-
lyzed. The flexibility (allosteric) behavior of the enzyme
may be understood in terms of the results of flexibility
analysis of this protein, which identified two modes of
motion that are also proposed to be involved in the
hyaluronan degradation process. The first motion de-
scribes an opening and closing of the catalytic cleft lo-
cated between the - and -domains. The second motion
demonstrates the mobility of a binding cleft, which may
facilitate the binding of the negatively charged hyaluro-
nan to the enzyme.
Streptococcus pneumoniae colonizes predominantly the up-
per respiratory tract of humans and is a major human patho-
genic bacterium. It is one of the key causes of life-threatening
disease such as pneumonia, bacteremia, and meningitis (1). It
also causes less threatening diseases that are, however, very
prevalent like otitis media and sinusitis (2). Pneumococci in-
teract with the host and its tissues through the surface sugars
(capsule) and a variety of usually surface-exposed protein mol-
ecules. These interactions are essential for the full pathogenic-
ity of these bacteria and are likely involved in the disease-
causing processes. The proteins known to be involved in this
interaction include, among others, hyaluronate lyase (3, 4),
pneumolysin (5), pneumococcal surface protein A (6), and pneu-
mococcal surface antigen A (7, 8).
S. pneumoniae hyaluronate lyase (SpnHL)1 primarily de-
grades hyaluronan (HA), the predominant polysaccharide com-
ponent of animal and human connective tissues and the nerv-
ous system, into unsaturated disaccharide units as the end
products (9). Cells in the connective tissues are embedded in
the strikingly viscoelastic HA matrix. Hyaluronan is a poly-
meric glycan composed of linear repeats of a few hundred to as
many as 20,000 or more disaccharide units of glucuronic acid
and N-acetylglucosamine. The glycosidic linkage present
within the disaccharide unit is -1,3, whereas the disaccharide
units are connected with the -1,4-glycosidic linkage. The HA
metabolism seems to be more significant than the metabolism
of other polysaccharides in vivo due to the large turnover of this
sugar. In human, one-third of the HA (about 5 g) is turned over
daily (10). The rapid turnover rate facilitates the use of HA and
its degradation products in many physiological processes, such
as cell differentiation and development (11), cell proliferation,
recognition, locomotion, and the immunological responses (12).
Enzymes of either mammalian (including host or human
enzymes) or bacterial origin degrade HA at the -1,4-linkage
exerting the eno- and exogenous pressures on the host. Bacte-
ria secrete hyaluronate lyases to degrade HA, and these en-
zymes usually produce unsaturated di-, tetra- (HA4), or hexas-
accharides (HA6). The mechanism of this degradation by
Streptococcus species hyaluronate lyase, which produces pri-
marily unsaturated disaccharides of HA, 2-acetamido-2-deoxy-
3-O-(-D-gluco-4-enepyranosyluronic acid)-D-glucose, as the
end products, was recently proposed and involves the elimina-
tion reaction introducing an unsaturated bond to the product
(9). Mammals, on the other hand, express hyaluronidases to
degrade HA and to produce relatively longer oligosaccharides
(13). The detailed atomic mechanism of HA degradation by
mammal hyaluronidases is still largely unknown due, in part,
to the lack of structural information. This process likely relies
on the displacement mechanism based on hydrolysis, similar to
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that of cellulases, to degrade the HA substrate (13). Mamma-
lian hyaluronidases (mainly bovine hyaluronidase) are, how-
ever, widely used in clinics, for example as an additive to the
local anesthesia for the fast spreading and penetration of med-
ications through tissues (14, 15).
The structure of the native SpnHL (9) and its complex with
the disaccharide products of HA degradation (16) were recently
reported. This structural information together with further
characterization of the enzyme (17, 18) allowed for the formu-
lation of the proposed mechanism of HA degradation (9, 13).
Briefly, the mechanism of catalysis, termed proton acceptance
and donation, involves a five-step process involving neutraliza-
tion of the carboxylate of a glucuronic moiety, extraction of a
proton from C-5 followed by a double bond formation in the
glucuronate and breaking of the -1,4-glycosidic linkage. Addi-
tional comparison to other enzymes degrading glycans like
Streptococcus agalactiae hyaluronate lyase (19), Flavobacte-
rium heparinum chondroitin AC lyase (20), and Sphingomonas
species alginate lyase A1-III (21) allowed for generalization of
the pneumococcal enzyme mechanism and suggested a similar
mechanism of action for these additional enzymes (13). Here we
report the structures of the S. pneumoniae hyaluronate lyase
complexes with its substrates, the tetra- and hexasaccharide
units of hyaluronan, and we discuss their implications for the
mechanism of action of the enzyme.
EXPERIMENTAL PROCEDURES
Enzyme and Substrate Preparation, Crystallization of Complexes,
and Collection of Diffraction Data—The SpnHL Y408F mutant cloning,
overexpression in Escherichia coli (pMJJ004), and purification were
reported previously (9, 22). The mutant enzyme was concentrated to 5
mg/ml in 10 mM Tris-HCl, pH 7.4, 2 mM EDTA, and 1 mM DL-dithio-
threitol and stored at 80 °C until their use. The tetra- and hexasac-
charide substrates were also obtained as described previously (17, 18).
To prevent degradation they were stored frozen at 80 °C in 10 mM
Tris-HCl buffer, pH 8.0, until their use.
The crystals of Y408F mutant version of SpnHL were obtained using
the same conditions as for the native enzyme crystals (100 mM sodium
cacodylate buffer, pH 6.0, 2.9 M ammonium sulfate) but with the addi-
tion of 5 mM EDTA (23). Crystallization of Y408F mutant enzyme was
accomplished using the vapor diffusion hanging drop method in 24-well
Linbro culture plates using equal volumes of the protein sample and the
reservoir solution (2 l of each) at 22 °C (24, 25). The protein and
reservoir solution were mixed and equilibrated against 1.0 ml of reser-
voir solution. Diffraction quality rectangular block shaped crystals of
Y408F (0.5  0.3  0.3 mm) were grown within several days. The
crystals of Y408F SpnHL were then soaked at room temperature with
20 mM tetra- and hexasaccharide substrates (both in 10 mM Tris-HCl
buffer at pH 8.0) for 10 h directly before the x-ray diffraction data
collection. The crystal soaking solution contained the crystallization
conditions (100 mM sodium cacodylate buffer, pH 6.0) with increased
concentration of the precipitation agent, ammonium sulfate, to 3.2 M.
The crystal was cryo-protected using the same conditions as for the
native crystals (23) and flash freezing them at 170 °C in a nitrogen
flow using a Cryostream Cooler (Cryosystems, Oxford, UK). The dif-
fraction data sets were collected using synchrotron radiation at the
wavelength of 1.0 Å at the 19-BM beamline at the Argonne National
Laboratory, Advanced Photon Source, Structural Biology Center using
an Oxford 3  3 charged-coupled device detector. The diffraction limits
of the crystals were 1.52- and 2.0-Å resolution for the tetra- and hex-
asaccharide complexes, respectively. The data were processed and
scaled using the HKL2000 package (26). The crystals of complexes were
isomorphous to the native ones. The final data processing parameters
are reported in Table I.
Determination of Structures of Complexes with Tetra- and Hexasac-
charides—The native SpnHL crystal structure without water molecules
(9) was used as the model for the complex structure solution. The Rfree
flag was assigned to 1 (1,249 reflections) and 2% (1,205 reflections)
reflections for the tetra- and hexasaccharide complexes, respectively, to
validate the refinement progress (27). Initially, a round of rigid body
refinements using only the model was performed using X-PLOR (28).
The Tyr408 was manually mutated to Phe using the O program (29).
Refinements progress using program X-PLOR with the positional and
simulated annealing protocols (28, 30) and was traced using inspection
on graphics with program O (29). The structures were refined against
124,927 and 60,437 reflections for the tetra- and hexasaccharide com-
plexes, respectively, and utilizing all data from 50 Å to the highest
resolution available and a 2(F) cut-off (Table I). The electron density
for the substrates was then clearly identified, and the incorporation of
the substrates into this density was followed. The topologies and pa-
rameter files for both substrates were manually created following our
earlier studies with disaccharide substrates and carefully corrected to
reflect ideal stereochemical values (16). Additional refinements includ-
ing individual restrained B-factor refinements, inspection, and manip-
ulation of structure on graphics using O together with incorporation of
water molecules placed into 3 peaks in -A weighted Fo  Fc maps
following standard criteria were performed. After refinement, water
molecules whose positions were not supported by electron density, at 1
contouring, in -A weighted 2Fo  Fc maps were deleted. A variety of
stereochemical (31) and other analyses (29, 32) was periodically per-
formed in order to locate possible model errors. The tetra- and hexa-
saccharide substrate molecules and 685 and 590 waters were incorpo-
rated, respectively, into the final structures of these two complexes.
Final refinement parameters are reported in Table I.
Flexibility Analysis and CONCOORD Simulations—The CONCO-
ORD program (33, 34) generates uncorrelated protein structures fulfill-
ing a set of upper and lower interatomic distance limits. These limits
are derived from experimental structures through measurement of
interatomic distances and prediction of the interaction strength of the
involved atoms. Thus, the separation of strongly interacting atoms was
allowed to vary only slightly from the observed value, whereas weaker
interactions have more relaxed limits. Special consideration was given
to interacting atoms within the same secondary structure element in
order to ensure the preservation of secondary structure. Although de-
tailed aspects of dynamic variation may not be reproduced by this
method, good qualitative agreement has been found between the results
of the conventional molecular dynamics and CONCOORD simulations
(33–35). Trajectories containing 500 conformations were calculated.
Essential Dynamics Calculations—The essential dynamics (ED) was
performed by Gromacs 3.0 (36, 37). This method is based on the diago-
nalization of the covariance matrix of atomic fluctuations, which yields
a set of eigenvalues and eigenvectors (38). The eigenvectors indicate
directions in a 3N dimensional space (where N  number of atoms) and
describe concerted fluctuations of the atoms, constructed such that the
amount of fluctuation along a small number of eigenvectors is maxi-
mized. The eigenvalues reflect the magnitude of the fluctuation along
with the respective eigenvectors. The central hypothesis of this method
is that the motions along the eigenvectors with the largest eigenvalues
are essential for describing the function. The motion along any desired
eigenvector can be inspected by projecting the frames from the trajec-
tory onto that eigenvector.
The figures were prepared using Ribbons (39), Grasp (40), O (29), and
Molscript (41).
RESULTS AND DISCUSSION
Choice of the Mutant Enzyme and Substrates—The native
S. pneumoniae hyaluronate lyase enzyme used in our studies
was active in the crystallized form. When crystal was combined
with the hyaluronan substrates, the degradation to disaccha-
rides was observed. This led to three-dimensional structures
for the complexes identical to that of the complex with the
disaccharide product reported earlier (16) (data not shown).
The presence in crystals of EDTA, to chelate divalent cations
such as calcium, which are required for full enzyme activity,
was not sufficient to totally prevent substrate degradation by
the enzyme (data not shown). The use of an inactive mutant of
the enzyme was, therefore, necessary to obtain complexes of
the hyaluronan-derived substrates larger than disaccharide
HA with the enzyme. Our earlier studies (9) showed that the
Y408F mutant of the enzyme is essentially inactive, and for
this reason this mutant form of the enzyme was chosen for our
studies. Indeed, the tetra- and hexasaccharide HA substrates
were not degraded by the enzyme during complex formation in
the crystals. The Y408F mutant enzyme consisted of residues
Ala168 to Gln892 of the full-length protein and a C-terminal His6
tag engineered for the ease of purification (22).
The tetra- and hexasaccharide hyaluronan substrates were
chosen because our earlier modeling studies (9, 16) suggested
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that they should fit entirely within the catalytic cleft of the
enzyme and not interfere with the crystallization process.
These truncated hyaluronan substrates were produced in mil-
ligram quantities from a human umbilical cord hyaluronan by
a controlled degradation with Streptomyces hyaluroliticus hy-
aluronate lyase as reported previously (9, 42, 43). This enzyme
is an eliminase and produces tetra- and hexasaccharides with
an unsaturated uronic acid at their non-reducing end as the
final degradation products. These products were identified us-
ing ion spray mass spectrometry experiments.
Solution and Refinement of Structures of Complexes—The
crystals of the inactive Y408F mutant form of the enzyme were
obtained using the hanging drop vapor diffusion method and
essentially the original crystallization condition of the native
enzyme reported previously (23). The crystals of the complexes
were obtained by soaking the Y408F mutant enzyme crystals
with 20 mM tetra- and hexasaccharides of HA for a relatively
short time directly before the freezing the crystals and/or
diffraction data collection. The best soaking time was deter-
mined to be 10 h. The diffraction data were collected and
processed, and structures were solved and refined as described
under “Experimental Procedures.” The data in Table I show
well refined structures with excellent stereochemistry. In a
Ramachandran plot (31), a majority of the residues for the
tetra- and hexasaccharide complexes are located in the most
favored areas and none in the disallowed or generously allowed
areas. These crystal structures were solved at 1.52- and 2.0-Å
resolution, respectively (Fig. 1). The tetrasaccharide complex
structure contains residues Lys171 to Lys889, and three N-
terminal residues and three C-terminal residues together with
the C-terminal His6 tag were not seen in the electron density.
For the hexasaccharide complex one additional residue on each
end of the molecule was partially located in the electron density
maps and was modeled as alanine. The electron density was
very clear for the entire structure of both complexes, including
the substrate molecules, with the exception of the very N and C
termini of the enzyme where disorder was evident (Fig. 2). The
structure of the complex with the tetrasaccharide contained
685 ordered water molecules, whereas that of hexasaccharide
includes 590 water molecules in addition to protein and sub-
strate molecules. For both substrates, there was only one sub-
strate molecule bound per molecule of the enzyme.
Description of the Complex Structures—The protein compo-
nents of both crystal structures of the complexes are nearly
identical to one another as well as to the structure of the native
enzyme (9). Briefly, the protein molecules are built from two
structural domains connected only by one short and flexible
linker peptide consisting from 11 amino acid residues (Fig. 1).
The structural domains are the N-terminal -helical domain
(-domain) and the C-terminal -sheet domain (-domain). The
-domain is composed of 13 helices arranged in a 5/5-barrel
structure (Fig. 1). The larger end of this barrel is shaped as a
deep and elongated cleft, which faces the -domain. The -do-
main is primarily composed of five anti-parallel -sheet struc-
tures forming a -sandwich. A part of this domain is in close
proximity to the cleft present in the -domain. However, its
contribution to the shape of the cleft is minimal and restricted
to two loops between the -sheets of the -domain, which
contribute to the shape of a part of one edge of the cleft (Fig. 1).
The cleft contains the substrate-binding site and catalytic res-
FIG. 1. Ribbon drawing of S. pneumoniae hyaluronate lyase
complex with the tetrasaccharide hyaluronan substrate. Both
domains of the enzyme are shown, the -helical domain (-domain, top)
and the -sheet domain (-domain, bottom), as well as the cleft with the
bound tetrasaccharide of hyaluronan. The structure of the enzyme is
color-coded by the secondary structure elements. The N and C termini
are labeled as N- and -C.
TABLE I
Crystallographic statistics of diffraction data and structure refinement of S. pneumoniae hyaluronate lyase complexes with
tetra- and hexasaccharide hyaluronan substrates
SpnHL-HA4 complex SpnHL-HA6 complex
Space group P212121 P212121
Unit cell dimensions (Å) a  83.7, b  103.8, c  101.3 a  83.7, b  103.6, c  101.3
Resolution range (Å) 50.00–1.52 50.00–2.00
Measured reflections 904,361 407,437
Unique reflections 124,927 60,259
Completeness (last shell) (%)a 93.1 (49.8) 99.9 (99.4)
Rmerge
b (last shell) (%) 8.0 (61.1) 16.7 (91.0)
Final model 719 amino acids, 585 waters 721 amino acids, 590 waters
Rcryst
c (last shell) 19.00 (33.0) 22.4 (32.4)
Rfree
d (last shell) 23.9 (39.5) 24.3 (38.4)
R.m.s.d.e bonds (Å) 0.006 0.007
R.m.s.d.e angles 1.235 1.305
Average B-factors (Å2)
Whole protein 45.08 26.24
-Domain 48.40 29.18
-Domain 41.36 23.20
Water molecules 53.48 34.22
Substrates 67.27 20.21
a The last shell is defined as 1.52–1.59 Å for the tetrasaccharide complex and 2.0–2.07 Å for the hexasaccharide complex.
b Rmerge  Ii  ‹I›/Ii  100 where Ii is the intensity of an individual reflection, and ‹I› is the mean of all reflection.
c Rcrys  Fp  Fcalc/Fp  100 where Fp and Fcalc are the measured and the calculated structure factors, respectively.
d Rfree is as defined by Brunger and Krukowski (55).
e R.m.s.d., root mean square deviation.
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idues. The detailed description of the native structure has been
reported elsewhere (9).
Structure and Conformation of the Tetra- and Hexasaccha-
ride Hyaluronan Substrates—The structures of both tetra- and
hexasaccharide HA substrates are similar in their orientation
and placement in the cleft of the enzyme (Figs. 2 and 3). The
tetrasaccharide position in the cleft essentially overlaps with a
portion of the hexasaccharide substrate at its reducing end. In
naming the disaccharide units of HA from the reducing to the
non-reducing end, this portion consists of HA1 and HA2. HA3
is unique to the hexasaccharide complex. The sugar rings (N-
acetyl--D-glucosamine and -D-glucuronate rings) of both sub-
strates are in chair conformations with the exception of the
terminal sugar rings of the unsaturated -D-glucuronates lo-
cated at the nonreducing end of both substrates (which are
unsaturated due to the presence of the double bond between
C-4 and C-5 introduced during substrate production, HA3 for
hexasaccharide and HA2 for tetrasaccharide) that are in dis-
torted half-chair conformations. Both substrates, including the
sugar ring substituents, fit well within clearly defined electron
density. The majority of substituents of the sugar rings was
clearly identified in such densities. The current structures
closely resemble and agree with our earlier modeling studies (9,
16) of both tetra- and hexasaccharides in the cleft of the native
enzyme. There are number of interactions between the sub-
strates and the enzyme residues including the catalytic, hydro-
phobic, positive, or negative patch residues. There are no pre-
dominant interactions responsible for substrate binding, rather
the binding of the substrate is accomplished by numerous in-
teractions of HA with multiple residues of the enzyme. Such
binding is consistent with the processive character of the en-
zyme as described below.
The Catalytic Cleft and the Active Site—The substrate-bind-
ing cleft is located at the larger end of the 5/5 barrel, and its
surface is built primarily from loop areas between the helices of
the -domain. The only residues from the -domain contribut-
ing to the cleft are two loops between -strands, encompassing
residues 578–583 and 766–771. The cleft dimensions are 30 Å
in length, 10 Å in width, and 14 Å in depth. Such an elongated
and relatively wide cleft allows for easy access of the elongated
FIG. 2. Electron density maps for the substrate molecules in
the structure of their complexes with the enzyme. The figure
shows a stereo view of the 2Fo Fc electron density maps contoured at
1 level. a, electron density for tetrasaccharide hyaluronan. b, electron
density for hexasaccharide hyaluronan.
FIG. 3. Protein-substrate interface in the structures of com-
plexes. The hexasaccharide hyaluronan substrate molecule is colored
in light brown and the protein ribbon in blue. The substrate and se-
lected residues are shown in a ball and stick style using standard colors
for spheres representing atoms. a, a stereo view of enzyme-hexasaccha-
ride hyaluronan interface. b, overlap between the tetra- and hexasac-
charide hyaluronan substrates bound in the cleft of the enzyme. Hex-
asaccharide hyaluronan is colored in red and tetrasaccharide in green.
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HA substrate. The surface of the cleft is highly electropositive
due to the abundance of basic residues at its surface. Hyaluro-
nan is electronegative due to the negative charges of the car-
boxylate groups along its chain, and it also has significant
hydrophobic character (44). The charge complementarity be-
tween the cleft and HA allows for electrostatic interactions
between the enzyme and the substrate resulting in substrate
binding. The predominant features of the cleft are as follows:
(a) multiple basic residues lining the cleft surface making it
highly positively charged and thereby facilitating substrate
binding; (b) a cluster of three negatively charged residues,
Glu388, Asp398, and Thr400, located at the terminal part of the
cleft that form a negative patch implicated in product release
(reducing end of the bound substrate, see below); (c) three
closely placed aromatic/hydrophobic residues, Trp291, Trp292,
and Phe343, located next to the catalytic residues of the cleft
and forming a hydrophobic patch that is implicated in precise
positioning of the substrate for the catalysis; and (d) three
residues, Asn349, His399, and Tyr408, that are proposed to be
directly involved in catalysis (Figs. 3 and 4).
Based on our earlier site-directed mutation studies, a group
of 5 residues was considered to affect directly the catalytic
process with 3 of them involved in the catalytic process, Asn349,
His399, and Tyr408, and the remaining 2, Arg243 and Asn580,
involved in substrate binding. These five mutant enzymes were
produced (R243V, N349A, H399A, Y408F, and N580A) and
characterized kinetically, and the correlations between the ki-
netic properties and the structure were made (Fig. 3) (9, 17).
Both the structure and the kinetic analysis of the three cata-
lytic residues Asn349, His399, and Tyr408 were shown to be
involved directly in catalysis, and their mutations caused sig-
nificant changes in the Km, Vmax, and Vmax/Km kinetic param-
eters. Similarly, two additional residues, Arg243 and Asn580,
were implicated in substrate binding and translocation but not
catalysis (9, 17). The native enzyme obeyed Michaelis-Menten
kinetics.
The degradation of HA is thought to be processive with the
random initial endolytic enzyme binding to hyaluronan fol-
lowed by exolytic degradation of the same substrate chain
toward its non-reducing end until the whole substrate was
degraded (Fig. 5) (17, 45). For the pneumococcal hyaluronate
lyase, and for several other known bacterial hyaluronate
lyases, the final degradation product is an unsaturated disac-
charide derivative of hyaluronic acid (22). The analysis of the
native structure, its modeled or x-ray crystal complex struc-
FIG. 4. Active center of S. pneumoniae hyaluronate lyase. The
hexasaccharide substrate chain is shown with selected residues of the
cleft: catalytic group (Asn349, His399, and Phe408 (Tyr408 was mutated to
Phe for the current structural studies)), hydrophobic patch (Trp291,
Trp292, and Phe343), and negative patch (Glu388, Asp398, and Thr400).
Interactions of the catalytic group residues and their targeted substrate
atoms are shown by lines. The substrate chain is shown in yellow, and
enzyme residues are shown in standard colors corresponding to atom
type. The reducing and non-reducing ends of the substrate are labeled.
Both ends of substrates may extend to include longer polymeric hyalu-
ronan chain. The -1,4-glycosidic linkage between HA1 and HA2 posi-
tions is to be cleaved.
FIG. 5. Schematic diagrams of hyaluronan degradation. a, over-
all mechanism of hyaluronate lyase action. The abbreviations used are:
E, enzyme; S, hyaluronan substrate; EPD, enzyme with bound trun-
cated hyaluronan substrate and a disaccharide product; EP, enzyme
with bound truncated hyaluronan substrate and disaccharide product
released from the active site of the enzyme. b, the catalytic mechanism
of hyaluronan degradation. The catalytic residues and their relative
position to the substrate were shown to illustrate the mechanism of HA
degradation as described in the text. The side chain position of Tyr408
has been modeled on the basis of the Y408F mutant structure. c,
structural alignment of S. pneumoniae and S. agalactiae hyaluronate
lyase. The pneumococcal enzyme is drawn in violet, and the S. agalac-
tiae enzyme is shown in chartreuse. The catalytic residues of both
enzymes are highlighted using the same colors. The similarity in the
overall three-dimensional structures, sequence, and structure identity
of the catalytic center suggest the same mechanism of action of both
enzymes.
Degradation of Hyaluronan 28291
 at M
ax Planck Inst.Biophysikalische Chem
ie,O
tto Hahn Bibl,Pf.2841,37018 G









tures with substrates and products of degradation, mutation
studies, and the kinetic analysis allowed for the formulation of
a five-step catalytic process responsible for HA degradation.
This process was proposed to consist from the following: (i) a
hyaluronan substrate binding step, (ii) a catalytic step, (iii)
hydrogen exchange with the water microenvironment, (iv) an
irreversible product release step, and (v) a translocation of the
remaining polymeric substrate step (Fig. 5a) (9). These steps
are described in more detail below.
Hyaluronan Binding in the Substrate Binding Cleft of the
Enzyme—In order for the hyaluronan degradation process to be
feasible, the enzyme needs to bind to the substrate utilizing its
elongated cleft. However, the immobilized structure of the en-
zyme in the crystals might not totally reflect the possible
changes in and the dynamics of the structural properties of this
enzyme. As shown below using a flexibility analysis based on
dynamics calculations, the -domain of the enzyme might have
a significant degree of mobility with respect to the -domain.
Therefore, it is possible that the -domain modulates the access
of substrate to the catalytic cleft by opening up or closing down
the entrance to this cleft (see below). The Asn580 residue of the
-domain contributes to the cleft formation in its narrowest
part, and mutation of this residue to one with a smaller side
chain, Gly, likely widens the cleft entrance. An N580G mutant
showed significantly higher activity as the wild type enzyme (9,
17) suggesting that cleft opening had allowed for easier binding
of the substrate. The Km and Vmax kinetic parameters of the
N580G mutant enzyme are 0.99  0.22 mM and 725  61
mmol/(minmg), respectively. Corresponding values for the na-
tive enzyme were determined to be 0.08  0.04 mM and 563 
18 mmol/(minmg) (17). The comparison of these kinetic param-
eters clearly shows that the N580G binds the substrate with a
lesser affinity (Vmax/Km  732 for the mutant and 7038 for the
wild type enzyme) but is a more efficient enzyme in translocat-
ing the nascent product/substrate (higher Vmax), a property
that may be directly related to the width of the cleft opening.
After the initial binding or docking of the substrate in the
cleft, hyaluronan is precisely positioned along the cleft inter-
acting predominantly with charged residues lining the cleft
surface (9). The importance of this process is reflected by the
loss of activity of the R243V mutant. As the current complex
structures show, the Arg243 residue interacts directly with the
carboxylate of the glucuronic acid moiety of the penultimate
disaccharide (Table II and Fig. 3a) and as such has the ability
to align the substrate directly along the cleft. Mutation of
Arg243 to Val disturbs this precise alignment along the cleft
axis, and the enzyme loses significant activity (17).
The substrate chain also is oriented such that the reducing
end of the chain is located at the narrower end of the cleft
where catalysis is performed (9, 16, 19). Such unidirectional
binding of hyaluronan determines its direction of degradation
by the enzyme from the reducing to the non-reducing end (see
below). The positions of the three-disaccharide units of the HA6
substrate bound in the cleft are termed HA1, HA2, and HA3
TABLE II
Selected interactions of hyaluronate lyase residues with the substrate molecules
The symbols assigned to the substrate atoms follow standard chemical nomenclature for sugar molecules.
Substrate/water atoms Enzyme/water residues and atoms Distance forHA4
Distance for
HA6
NAcla of HA1 (Å)
C-3 Trp291 NE1 3.86 3.95
C-6 Phe343 CD1 3.80 3.70
O-3 Trp291 NE1 2.87 2.89
O-4 Phe343 CZ 3.94 4.00
O-5 Asn336 NH2 3.56 3.66
O-6 Glu388 OE2 3.83 3.94
O-7 Trp291 NE1 3.59 3.61
UA1 of HA1
O-4 (glycosidic oxygen between HA1 and HA2) Phe408 CZ (Tyr408 OH)b 4.63 (3.10) 4.55 (3.18)
Arg462 NH2 3.02 3.16
Wat1 4.04 4.07
Wat2 4.61 3.41
O-5 His399 NE2 3.66 3.73
O-6 (glucuronate CO2) Asp
349 OD1 3.12 2.98
O-7 (glucuronate CO2) Asp
349 ND2 3.56 3.34
Wat3 His399 NE2 6.99 6.30
Wat4 His399 NE2 6.39 6.73
NAc2 of HA2
O-3 Arg466 NH1 3.34 3.22
Arg466 NH2 3.67 3.82
O-5 Trp292 CD2 3.83 3.89
O-7 Arg466 NH2 2.94 2.97
UA2 of HA2
O-2 Arg466 NH1 2.63 3.74
O-6 (glucuronate CO2) Arg
243 NH1 3.63 2.24
O-7 (glucuronate CO2) Arg
243 NH2 3.63 2.90
NAc3 of HA3
O-3 Arg300 NH2 NAc 3.51
O-6 Asn418 OE1 NA 3.59
Asp414 OD1 NA 3.52
UA3 of HA3
O-2 Glu246 OE2 NA 2.31
O-4 Lys250 NZ NA 2.93
O-6 (glucuronate CO2) Asn
418 NE2 NA 3.39
O-7 (glucuronate CO2) Asn
418 NE2 NA 3.34
a UA1, UA2, and UA3 denote the -D-glucuronic acid of HA1, HA2, and HA3, respectively, whereas NAc1, NAc2, and NAc3 denote N-acetyl--
D-glucosamine of HA1, HA2, and HA3, respectively.
b The distance in parentheses corresponds to the distance between the modeled Tyr408 OH atom position based on the native enzyme structure
position of Tyr408 residue and the glycosidic oxygen of the corresponding complex structure.
c NA, not applicable.
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from the reducing to the non-reducing end of the substrate and
similarly HA1 and HA2 disaccharide units for the HA4
substrate.
Finally, directly next to the catalytic residues determined by
our earlier research (9), there are three hydrophobic residues,
Trp292, Trp291, and Phe343, creating a hydrophobic area in the
cleft termed aromatic/hydrophobic patch (Fig. 4). These resi-
dues interact with the substrate utilizing the hydrophobic in-
character sugar rings of the first and the penultimate disac-
charide units of the substrates. Trp292 interacts with the HA2
unit, whereas Trp291 and Phe343 interact with the HA1 disac-
charide unit of both the hexa- and tetrasaccharides. In this
way, these three residues precisely position the substrate and
its chemical groups in positions most suitable for catalysis
performed by three catalytic residues Asn349, His399, and
Tyr408 (Figs. 4 and 5b). The binding of the substrate in the
opposite direction is not favored because it creates significant
steric clashes between the enzyme and the substrate, and the
catalytic residues are not positioned favorably with respect to
the substrate for catalysis.
Catalytic Cleavage of the Glycosidic Bond—We have pro-
posed previously (9), based on the structure of the native en-
zyme and its modeled complex structure with the tetra- and
hexasaccharide units of HA, its complex structure with the
disaccharide product of degradation (16) and mutation studies
(9, 17) that the catalytic residues are Asn349, His399, and Tyr408
(Fig 5b). The current complex structures with the tetra- and
hexasaccharide HA units confirm our earlier conclusions. As
shown in Table II, Asn349 directly interacts in a bidentate
fashion with the carboxylate group of the glucuronate moiety of
HA1. This interaction allows Asn349 to act as a partial electron
sink by attracting the electronegative charge of the carboxyl
group of HA1 away from the C-5 of glucuronate. This process
leads to acidification of the C-5 hydrogen that normally has a
high pKa value, which is estimated to be in the range from 29
to 32 (46). As a consequence, His399 acting as a base can
withdraw this hydrogen, and the C-5 is rehybridized to the sp2
hybridization. In the complex structures His399 is in direct
contact with the C-5 of the glucuronate moiety (Table II), which
supports our suggestion. At the same time Tyr408 acts as an
acid and donates hydrogen to the glycosidic oxygen leading to
cleavage of its -1,4 covalent glycosidic bond between HA1 and
HA2. The C-4 is then rehybridized to the sp2 hybridization, and
a double bond is formed between C-4 and C-5 (Fig. 5b).
To avoid substrate degradation, we used a Y408F mutant
enzyme to obtain the complex structures reported here. There-
fore, the distance between the Tyr408 and the glycosidic oxygen
could not be determined; however, the distances of 4.55 Å for
the HA6 complex and 4.63 for the HA4 complex between Phe
408
and the glycosidic oxygen, O4, are consistent with the proposed
role of Tyr408. Furthermore, the corresponding distances based
on the modeled position of Tyr408 (Table II) are 3.18 and 3.10 Å.
There are two other residues, Arg462 and Arg466, that are in
close proximity to the glycosidic oxygen and could in principle
serve as acids to donate hydrogen to the glycosidic oxygen (Fig.
3). Their possible contribution to catalysis cannot be discarded
although the pKa of Arg is significantly higher that that of Tyr
so that their participation seems unlikely.
Hydrogen Exchange with Microenvironment—In the cata-
lytic process described above, the enzyme molecule loses one
hydrogen from Tyr408 and gains another one at His399. As the
final step, the hydrogen balance needs to be restored for the
enzyme to return to its original state and be ready for the next
round of catalysis. There is no evidence in the structure of
hydrogen channeling using ordered water molecules or resi-
dues of the enzyme. The closest structured water molecules,
Wat3 and Wat4, identified in the electron density in the prox-
imity of His399 are more than 6 Å away (Table II and Fig. 3a).
No structured waters were identified anywhere close to the
Phe408 of Y498F enzyme complexes. Therefore, the hydrogens
are likely equilibrated using the unstructured water microen-
vironment present in the cleft of the enzyme.
For the next round of catalysis to take place, the enzyme also
needs to release the generated disaccharide product from the
active site. This can happen by either translocation of the
remaining polymeric HA substrate to the catalytic position by
an advance by one disaccharide unit toward its reducing end
(considered more likely) or by the release of the substrate from
the cleft thereby allowing the binding of a new substrate mol-
ecule to the enzyme.
Disaccharide Product Release—At the HA1 position in the
cleft, there are three negatively charged residues, Glu388,
Asp398, and Thr400, grouped together at the bottom of the cleft
surface, directly opposite the Phe343 amino acid residue of the
hydrophobic patch (Fig. 4). These residues are responsible for
the generation of a patch of negative potential (negative patch)
in the area of the cleft where the HA1 disaccharide of the
electronegative substrate binds (Fig. 6). The presence of this
patch is likely not coincidental but is probably important for
the function of the enzyme. Most likely, after catalysis when
the disaccharide product is cleaved off from the polymeric HA
substrate chain, this product is directly located in this poten-
tial. As a consequence, the product is electrostatically repelled
from the cleft. Such behavior rationalizes the release of the
product from the cleft. The electronegative patch simply facil-
itates this process and frees up this part of the cleft, making the
enzyme ready for the next round of catalysis.
Translocation of the Substrate and the Processive Mode of
Action of the Enzyme—After the release of the disaccharide
FIG. 6. Electrostatic potential distribution in the catalytic
cleft. The positive potential was shown in blue and negative potential
in red. The majority of the cleft is highly positively charged (middle and
the left side), whereas at the product-releasing end of the cleft a nega-
tive patch is clearly present (right side of the cleft). The hydrophobic
patch is hidden beneath the bridge over the substrate. The bridge over
the substrate cleft facilitates the threading of the substrate through the
cleft. The flexibility analysis (see the text) of the enzyme suggests that
this bridge is formed after substrate binding, and likely only during the
catalysis. Top, bound hexasaccharide hyaluronan shown as sticks. Bot-
tom, space filling hexasaccharide hyaluronan bound in the cleft.
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product, there remains a truncated polymeric HA in the cleft
that can become a substrate for further degradation. One pos-
sibility is that the substrate leaves the cleft and the enzyme
binds again a new or the same hyaluronan molecule into the
catalytic cleft (random endolytic or exolytic binding and then
cleavage). Alternatively, the molecule already bound in the
cleft could be translocated in the cleft by one disaccharide unit
toward the reducing end for the next round of catalysis (sub-
sequent processive exolytic binding and cleavage of unsatur-
ated hyaluronan disaccharides by the enzyme). The latter
seems to be the case as shown by the biochemical evidence
collected for the similar S. agalactiae hyaluronate lyase en-
zyme (47). As the S. pneumoniae enzyme is very similar in its
sequence and structural and functional properties to the
S. agalactiae enzyme from the same genus, it is reasonable to
assume that this enzyme behaves in the same way. The overall
sequence identity between the two enzymes is 51%, and se-
quence homology is 66%. In addition, the structures of both
enzymes show a high degree of similarity, especially in the
active site area (19, 22) (Fig. 5c). In this processive mechanism
of action of hyaluronate lyase, the enzyme probably binds ran-
domly to HA and cleaves it into two pieces (random endolytic or
exolytic cleavage), of which only the one at the reducing end
leaves the cleft (as described for the disaccharide product). The
remaining chain undergoes translocation in the cleft by one
disaccharide unit, and the catalysis goes on to generate another
disaccharide unit and so on until the chain is fully degraded
(exolytic processive degradation) (Fig. 5a).
To achieve translocation of a polymeric substrate in the
binding cleft, an essential component of the processive mecha-
nism, several main factors need to be in place as follows: (i)
complementary interfaces between the processive enzyme and
the substrate and appropriate shape of the binding cleft allow-
ing for easy substrate translocation or sliding; (ii) correct en-
ergetic balance of substrate-enzyme interactions allowing for
the substrate remaining to be associated with the enzyme after
catalysis but also retaining the ability to move along the cleft,
a sliding mechanism; (iii) mechanism allowing the enzyme to
locate the site of catalysis (location of the 1,4-glycosidic bond
to be broken) on the substrate during the translocation/sliding
process of the hyaluronan substrate (48); and finally (iv) a
mechanism for the release of the product of the reaction, a
disaccharide of HA for this hyaluronate lyase, to make room for
the remaining polymer to be translocated and for further ca-
talysis to go on. For pneumococcal hyaluronate lyase, all these
factors are satisfied. The cleft where the substrate binds is
long, straight, deep enough, and wide enough to easily accom-
modate the polymeric chain of HA, and the shapes of HA and
the cleft are complementary to one another (Fig. 6). The inter-
actions between the residues of the cleft and the substrate are
in general primarily based on interactions of charged elec-
tropositive residues lining the sides of the cleft with the elec-
tronegative substrate (Fig. 6). There are numerous interactions
of that sort between the enzyme residues and the substrate,
which likely allows for moderate binding affinity for the sub-
strate generated not by a few strong and specific interactions
but by a multitude of different, small binding interactions as
also observed for other processive enzymes (48). These interac-
tions are strong enough to bind and to keep the substrate in
place in the cleft; however, they are also weak enough to allow
the sliding/translocation of the polymer along the straight cleft
to advance the substrate and to move it into the new catalytic
position. Electrostatic interactions are known not to have sig-
nificant directionality associated with them, unlike hydrogen
bonds, for example, and can more easily allow for shifts main-
taining their interactions. Once such a translocation takes
place, a group of hydrophobic residues directly adjacent to the
three catalytic residues, termed by us as a hydrophobic patch
composed of Trp291, Trp292, and Phe343, precisely positions the
substrate. Especially, the positioning of the region in the close
proximity to the glycosidic -1,4 bond between the terminal
disaccharide to be freed from the polymer and the remaining
part of HA is essential for catalysis. This interaction is based on
hydrophobic interactions of the sugar rings of the substrate and
similar aromatic and hydrophobic structures of the side chains
of the above-mentioned residues. Specifically, HA1 disaccha-
ride interacts with Phe343 and partially with Trp291, whereas
Trp292 interacts with HA2; all residues utilize hydrophobic
interactions. Finally, the negative patch located at the reducing
end of the substrate/cleft provides a mechanism for the release
of the product of the reaction, the unsaturated disaccharide
unit of hyaluronan (Figs. 4 and 5).
Direction of Hyaluronan Degradation—The processive na-
ture of hyaluronan degradation leads to the question whether
this degradative process is performed from the reducing end of
the substrate to the nonreducing end or vice versa. Our current
structural report including the complexes of tetra- and hexa-
saccharide HA with the enzyme and our previous work (16, 19)
on the complex structures with the disaccharide products sug-
gests that the degradation takes place from the reducing to the
nonreducing end of hyaluronan. The current structures clearly
show that the cleavage of the -1,4-glycosidic bond between
HA1 and HA2 disaccharide units of the tetra- and hexasaccha-
ride substrates will produce an unsaturated disaccharide unit
of HA at the reducing end of the chain and a tetrasaccharide
(for the hexasaccharide complex) or a disaccharide (for the
tetrasaccharide complex). The tetrasaccharide product of the
degradation of the hexasaccharide can be further degraded to
disaccharides, whereas the disaccharide product of tetrasac-
charide degradation cannot be further degraded (17). The
translocation of the substrate in the reducing end direction
advances HA polymer to the new degradation position. In this
position the HA2 disaccharide took the place of the cleaved
HA1 disaccharide, and HA3 took the place of HA2 (Figs. 4 and
5). In addition, the presence of the negative patch at the reduc-
ing end of bound HA chain further identifies this reducing end
as the releasing end of the substrate. The structures of the
hyaluronate lyase enzyme with the bound product of degrada-
tion also support this analysis because no bound product was
found at the HA3 non-reducing position in the cleft (16, 19).
The possibility of the degradation of HA in the opposite direc-
tion from the non-reducing to the reducing end is clearly not
supported by the current structures of the complexes or by our
earlier studies.
Comparison of Hyaluronan Degradation to the Degradation
of Dermatan Sulfate, Chondroitin Sulfate, and Alginate— The
degradation of polysaccharides by polysaccharide lyases such
as hyaluronate lyase has been investigated for some time by
biochemical and structural methods (e.g. Refs. 49 and 50).
Recent structural investigations of F. heparinum chondroitin
AC lyase (20) and Sphingomonas species alginate lyase A1-III
(21) provided some additional insight into this process. The
overall fold of the F. heparinum chondroitin AC lyase (20) is
similar to that of S. pneumoniae hyaluronate lyase consisting
of two domains, a -helical and a -sheet domain. The -helical
domain contains a similar elongated cleft where the polymeric
sugar molecules bind and are cleaved. Several scenarios were
proposed for the chondroitin AC lyase mechanism of dermatan
sulfate, chondroitin sulfate, and hyaluronan degradation, and
these mechanisms involve His225 and Tyr234, residues corre-
sponding to His399 and Tyr408, respectively, of the pneumococ-
cal hyaluronate lyase. The homologous residue to Asn349 of the
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pneumococcal hyaluronate lyase, Asn175, has not been directly
implicated in the degradation mechanism for chondroitin AC
lyase by Huang et al. (20), although modeling studies and the
complex structures of the AC lyase showed that this residue
could interact with the carboxylate group of the C-5 of all
substrates (20). Also, the residue homologous to Arg462 of
S. pneumoniae lyase, Arg288, was implicated in the chondroitin
AC lyase mechanism as possibly a general acid acting as a
donor of hydrogen to the glycosidic oxygen during the cleavage
of this bond or as a charge-neutralizing residue for the enolate
anion intermediate formed during catalysis. Our analysis of
the active site of S. pneumoniae hyaluronate lyase does not
support such role of Arg462 for the pneumococcal lyase. Even
though Arg462 is in close proximity to the glycosidic oxygen of
hyaluronan (Table II), its pKa for hydrogen donation is signif-
icantly higher than that of Tyr408, and therefore the latter
residue is more likely to participate in this way. Mutation of
the homologous residue to Arg462 for the hyaluronate lyase
from S. agalactiae, Arg542, decreased but did not abolish the
activity of this enzyme (51) supporting our conclusions. This
Arg may have a structural role or be involved in substrate
FIG. 7. Stereo view of the superpo-
sition of the minimum and the maxi-
mum projection structures of hyalu-
ronate lyase. Motions described by
eigenvectors 1 (a) and 3 (b) are shown.
Green and red coils represent the mini-
mum and maximum projections, respec-
tively. a, -domain movement regulating
the access to the cleft. C atoms of the
positive patch residues are drawn as ma-
genta spheres. Residues from the active
center (Asn349, Tyr408, and His399) and
from the negative patch (Glu388, Asp398,
and Thr400) are drawn as blue and yellow
spheres, respectively, and labeled. b,
opening up and closing of the cleft. Move-
ment between the two domains, opening
and closing a pocket is shown (His399,
drawn as a sphere). Selected residues are
shown as cyan spheres and labeled (see
Table III for distance details between
these residues).
TABLE III
Distances between selected residues of the minimum and maximum
projection structures of eigenvector 3 resulting from the
CONCOORD simulations
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binding; either of these functions would reasonably explain the
reduced enzyme activity on its mutation.
Another recently studied polysaccharide degrading enzyme
is alginate lyase. The overall fold of the Sphingomonas species
alginate lyase A1-III elucidated structurally only recently (21)
is similar to that of the -domain of S. pneumoniae hyaluronate
lyase, but the -sheet domain is not present in this enzyme.
The -helical domain also supports the formation of a similar
elongated substrate-binding cleft to that of the pneumococcal
lyase. For the alginate lyase A1-III a Tyr246, homologous to
Tyr408 of the pneumococcal lyase, was suggested to act as both
a base withdrawing hydrogen from the C-5 of alginate and as
an acid donating hydrogen to the glycosidic oxygen (21). Al-
though this may be possible for the alginate lyase, we do not see
evidence for such behavior with hyaluronate lyase in our com-
plex structures nor from earlier studies (9, 13, 17, 19).
Protein Flexibility of Hyaluronate Lyase and Its Functional
Implications—Computational studies often can enable correla-
tions between mobility of proteins or their segments and spe-
cific functions (52). Concerted motions involving protein seg-
ments may be deduced from ED analysis of molecular dynamics
(MD) simulations (52–54). In the case of pneumococcal hyalu-
ronate lyase, its size precludes the realistic calculation of MD
trajectories at biologically relevant time scales. However, good
qualitative agreement between the results of ED analyses of
MD trajectories and the results of analysis of CONCOORD
software generated structures has been obtained (see “Experi-
mental Procedures”). We therefore applied the CONCO-
ORD/ED methodology to seek independent support for the pro-
posed roles of the dynamical features of the enzyme, in
particular in the region of the binding cleft and its catalytic
region.
The largest amplitude concerted fluctuation, mathematically
described by the first eigenvector, is a rotation/twisting motion
of the whole -domain relative to the top half of the -domain
(Fig. 1). Concomitantly, the bottom half of the -domain rotates
in the opposite direction, relative to the top half of that domain.
Fig. 7a shows the superimposition of the minimum and maxi-
mum projections for this first eigenvector. These projection
structures correspond to the two extreme structures associated
with this mode of fluctuation. The intra--domain motion
seems to be of little functional consequence because the inter-
face between the two dynamically independent portions of the
-domain lies distant to the active site. However, the residues
from the positively charged majority of the binding cleft of the
-domain of the enzyme (a positive patch) are particularly
mobile relative to residues from the active center and the
negative patch. This is consistent with the previous hypothesis
(19) that the mobility of the positive patch is related to drawing
the ligand into the binding cleft.
Another major motion of the hyaluronate lyase is also related
to an opening/closing of the substrate-binding cleft and is de-
scribed by eigenvector 3. Fig. 7b shows the superimposition of
the minimum and maximum projections for this mode of con-
certed fluctuation. The change of the distance between selected
residues involved in the movement is shown in Table III. The
residues from the active site and from the negative patch,
whose relative orientation did not change significantly with the
motion described by the first eigenvector, exhibit significant
relative positional shifts along the motion described by eigen-
vector 3. This finding is interesting given the obvious need of
the enzyme to release the electronegative disaccharide product
of degradation from the active site in order to enable relocation
and further processing of the remaining polysaccharide. In
addition, there is evidence for the mobility, relative to the
-domain, of two loops from the -domain, which are involved
in the cleft formation (described earlier). For example, Asn580,
which is located at the tip of one of the loops from the -domain,
shows a relatively large fluctuation (Table III). As described
above and supported by the earlier kinetic analysis (17), the
N508G mutant showed significantly higher activity when com-
pared with the wild type enzyme, confirming the importance of
this loop to catalysis. Therefore, the flexibility analysis sug-
gests that this opening/closing motion of the enzyme is directly
relevant not only to hyaluronan binding but also to the catal-
ysis itself.
Conclusions and Biological Implications—The current struc-
tures of hyaluronate lyase complexes with substrates enable us
to draw conclusions related to the functional properties of the
enzyme. The mechanism of catalysis was well established as
proton acceptance and donation. The comprehensive analysis
of the entire process of hyaluronan degradation was proposed
including the irreversible release of the disaccharide product
and the nature of the processive mechanism of this important
biological process. The residues involved in substrate binding,
precise positioning for catalysis, catalysis itself, the release of
the product, and the translocation of the remaining substrate
were clearly identified, and their contribution to the entire
degradation process was described. The nature of the proces-
sive behavior of hyaluronate lyase described here is likely
relevant to other processive enzymes. Finally, we presented
simulated molecular and essential dynamics analyses that
shed light on the aspects of the function of the enzyme that
would be inaccessible to evaluation of static crystal structures.
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